<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>33(12)</volume><submitter>Hans D</submitter><funding>University of Lausanne</funding><funding>Amgen</funding><pubmed_abstract>TBS algorithm has been updated to account for regional soft tissue noise. In postmenopausal women with osteoporosis, denosumab improved tissue thickness-adjusted TBS vs placebo independently of bone mineral density over 3 years, with the magnitude of changes from baseline or placebo numerically greater than body mass index-adjusted TBS.&lt;h4>Introduction&lt;/h4>To evaluate the effect of denosumab on bone microarchitecture assessed by trabecular bone score (TBS) in the FREEDOM study using the updated algorithm that accounts for regional soft tissue thickness (TBS&lt;sub>TT&lt;/sub>) in dual-energy X-ray absorptiometry (DXA) images and to compare percent changes from baseline and placebo with classical body mass index (BMI)-adjusted TBS (TBS&lt;sub>BMI&lt;/sub>).&lt;h4>Methods&lt;/h4>Postmenopausal women with lumb</pubmed_abstract><journal>Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA</journal><pagination>2517-2525</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9652244</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Updated trabecular bone score accounting for the soft tissue thickness (TBS&lt;sub>TT&lt;/sub>) demonstrated significantly improved bone microstructure with denosumab in the FREEDOM TBS post hoc analysis.</pubmed_title><pmcid>PMC9652244</pmcid><pubmed_authors>Huang S</pubmed_authors><pubmed_authors>Hans D</pubmed_authors><pubmed_authors>Shevroja E</pubmed_authors><pubmed_authors>McClung M</pubmed_authors><pubmed_authors>McDermott M</pubmed_authors><pubmed_authors>Kim M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Updated trabecular bone score accounting for the soft tissue thickness (TBS&lt;sub>TT&lt;/sub>) demonstrated significantly improved bone microstructure with denosumab in the FREEDOM TBS post hoc analysis.</name><description>TBS algorithm has been updated to account for regional soft tissue noise. In postmenopausal women with osteoporosis, denosumab improved tissue thickness-adjusted TBS vs placebo independently of bone mineral density over 3 years, with the magnitude of changes from baseline or placebo numerically greater than body mass index-adjusted TBS.&lt;h4>Introduction&lt;/h4>To evaluate the effect of denosumab on bone microarchitecture assessed by trabecular bone score (TBS) in the FREEDOM study using the updated algorithm that accounts for regional soft tissue thickness (TBS&lt;sub>TT&lt;/sub>) in dual-energy X-ray absorptiometry (DXA) images and to compare percent changes from baseline and placebo with classical body mass index (BMI)-adjusted TBS (TBS&lt;sub>BMI&lt;/sub>).&lt;h4>Methods&lt;/h4>Postmenopausal women with lumb</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2025-04-19T18:51:16.241Z</modification><creation>2025-04-19T18:51:16.241Z</creation></dates><accession>S-EPMC9652244</accession><cross_references><pubmed>36115888</pubmed><doi>10.1007/s00198-022-06549-x</doi></cross_references></HashMap>